Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

(3aS-(3aalpha,4beta,5beta,7beta,7aalpha))-4-(octahydro-5-hydroxy-4,7-dimethyl-1,3-dioxo-4,7-epoxy-2H-isoindol-2-yl)-2-iodobenzonitrile MeSH Supplementary Concept Data 2025


MeSH Supplementary
(3aS-(3aalpha,4beta,5beta,7beta,7aalpha))-4-(octahydro-5-hydroxy-4,7-dimethyl-1,3-dioxo-4,7-epoxy-2H-isoindol-2-yl)-2-iodobenzonitrile
Unique ID
C529326
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C529326
Entry Term(s)
OHDDEII cpd
Registry Numbers
0
Heading Mapped to
*Bridged Bicyclo Compounds, Heterocyclic
*Isoindoles
Frequency
1
Note
has potent in vivo efficacy after oral dosing in the CWR22 human prostate tumor xenograph model; structure in first source
Source
Bioorg Med Chem Lett 2008 Mar 15;18(6):1910-5
Date of Entry
2008/06/04
Revision Date
2008/06/04
(3aS-(3aalpha,4beta,5beta,7beta,7aalpha))-4-(octahydro-5-hydroxy-4,7-dimethyl-1,3-dioxo-4,7-epoxy-2H-isoindol-2-yl)-2-iodobenzonitrile Preferred
page delivered in 0.004s